September pharma slump could be a blip, but Singapore factory growth is set to cool

LOWER output in the volatile pharmaceuticals segment sent Singapore's manufacturing sector into negative territory in September, snapping a 10-month winning streak.

But the factory output decline is unlikely to persist in the coming months, even as growth cools on a high base and supply constraints, watchers said on Tuesday (Oct 26).

Industrial production missed private-sector analysts' expectations to shrink by 3.4 per cent year on year, reversing the 11.0 per cent expansion in August, according to data from the Economic Development Board (EDB).